Mapping tool highlights NIH-funded small business successes
On Aug. 13, 2020, the National Institutes of Health (NIH) announced a new interactive mapping tool that showcases…
-
-
Thermo Fisher Scientific supported COVID-19 testing at historically black colleges and universities seeking a safe return to campus
On Aug. 12, 2020, Thermo Fisher Scientific announced it had committed to supporting the efforts of historically black…
-
NIH harnessed AI for COVID-19 diagnosis, treatment, and monitoring
On Aug. 5, 2020, the National Institutes of Health (NIH) announced it had launched the Medical Imaging and…
-
BD received additional orders for 177 million injection devices for US, Canada COVID-19 vaccine preparations
On Jul. 21, 2020, BD (Becton, Dickinson) announced additional pandemic orders for needles and syringes from the U.S….
-
Biotechnology | Clinical Research | Diagnostics | FDA | Medical Device | Non-Profit Research | Oncology | Rare Disease | Stem Cell | Therapeutics | U.S. Congress
Tufts Center for the Study of Drug Development reported faster new drug approval times were more than offset by longer clinical Times in US
On Jul. 16, 2020, the Tufts Center for the Study of Drug Development reported that although regulatory approval…
-
Celdara Medical announced the Pandemic Security Initiative
On Jul. 14, 2020, Celdara Medical announced the launch of its Pandemic Security Initiative, harnessing the resources needed…
-
Philips and BioIntelliSense formed strategic collaboration to enhance remote patient monitoring at home
On Jul. 9, 2020, Royal Philips announced it had formed a strategic collaboration with BioIntelliSense, a continuous health…
-
Oxford scientists formed spinout to launch rapid Covid-19 virus test
On Jul. 7, 2020, scientists from the University of Oxford’s Department of Engineering Science and Oxford Suzhou Centre…
-
FDA issued Emergency Use Authorization for Philips’ acute care patient monitoring solutions for hospitals
On Jul. 2, 2020, Royal Philips announced that the U.S. Food and Drug Administration (FDA) had issued an…
-
U.S. Dept of Veterans Affairs launched COVID-19 screening tool
On Jun. 29, 2020, the U.S. Dept. of Veterans Affairs (VA) announced it had launched a digital COVID-19…
-
Todos Medical entered into distribution partnership with Meridian Health Services network for COVID-19 testing solutions
On Jun. 29, 2020, Todos Medical announced that it had entered into a partnership with Meridian Health Services…
-
Biotechnology | COVID-19 | Infectious Disease | Medical Device | Non-Profit Research | Therapeutics | Vaccine
COVID-19 Therapeutics Accelerator donors launched international alliance to connect research data sources and enable collaboration
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
-
Vaxart signed Memorandum of Understanding with Attwill Medical Solutions Sterilflow
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
-
Mayo Clinic launched imaging solution to enable digital pathology across the enterprise
On Jun. 25, 2020, in support of Mayo Clinic’s digital health and practice transformation initiatives, the Mayo Clinic…
-
INOVIO received $71 million contract from U.S. Department of Defense to scale up manufacture of CELLECTRA 3PSP smart device
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
-
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics
The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…
-
FDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, and relebactam) for Treatment of Adults with Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia
On Jun. 4, 2020, Merck announced that the U.S. Food and Drug Administration (FDA) had approved a supplemental…
-
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the Food and Drug Administration (FDA) announced it had issued an emergency use authorization…
-
Biogen and MIT launched virtual learning lab for high school students historically underrepresented in science
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
-
Philips launched next generation wearable biosensor for early patient deterioration detection for COVID-19
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
-
University of Nebraska developed a COVID-19 screening mobile app
On May 13, 2020, a new protective device that is expected to help protect healthcare workers everywhere from…
-
Todos Medical entered Into exclusive distribution agreement with Gnomegen and received FDA Emergency Use Authorization for COVID-19 qPCR test kits
On May 11, 2020, Todos Medical announced an exclusive distribution agreement with Gnomegen for the distribution of its…
-
AbbVie completed acquisition of Allergan for nearly $62 billion
On May 8, 2020, AbbVie announced it had completed its acquisition of Allergan following receipt of regulatory approval…
-
COVID-19 in-home monitoring program launched
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
-
Royal DSM accelerated Dutch Covid-19 testing by making 28 million nose swabs
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
-
Biotechnology | COVID-19 | Diagnostics | FDA | Infectious Disease | Medical Device | Non-Profit Research
OPTI Medical Systems received FDA Emergency Use Authorization for OPTI SARS-CoV-2 RNA PCR test kit for detection of Virus causing COVID-19
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
-
PharmaCyte Biotech received medical devices registration and submited pre-EUA application to the FDA for COVID-19 diagnostic kit
On May 6, 2020, PharmaCyte Biotech announced it had received Medical Devices Establishment Registration with the U.S. Food and…
-
3M and Ford begin shipping newly designed powered air-purifying respirators for health care workers fighting COVID-19
On May 6, 2020, 3M and Ford announced that newly designed powered air-purifying respirators (PAPRs), developed are on…
-
LabCorp announced availability of COVID-19 antibody test
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
-
Athersys Announces Commencement of Patient Enrollment in the MACOVIA Study, a Pivotal Phase 2/3 Trial Evaluating MultiStem® Cell Therapy for COVID-19 Induced ARDS
On May 5, 2020, Athersys announced that the first patients have been enrolled in Athersys’ pivotal Phase 2/3…
